"日本橋の内科クリニックです。＊内科 （糖尿病、高血圧症、脂質異常症、高尿酸血症、痛風、肥満症、甲状腺機能亢進症、甲状腺機能低下症、胃潰瘍、逆流性食道炎、十二指腸潰瘍、過敏性腸症候群IBD、機能性胃腸症FD、ウイルス性肝炎、非アルコール性脂肪性肝疾患NAFLD/非アルコール性脂肪性肝炎NASH、気管支喘息、慢性閉塞性肺疾患COPD、慢性腎臓病CKD、花粉症、線維筋痛症、むずむず脚症候群 等々）＊経鼻内視鏡 月曜AM 水曜PM 金曜AM＊眼科 木曜PM＊皮膚科 月曜水曜木曜金曜土曜AM 木曜PM"

During the past decade, Fukuwa Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fukuwa Clinic" are "Asthma" (1 trials) and "Dyslipidemias" (1 trials). Many other conditions were trialed in "Fukuwa Clinic" in a lesser frequency.

Most popular intervention types in "Fukuwa Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "K-877 ER 0.2 mg/day (once daily)" (1 trials), "K-877 ER 0.4 mg/day (once daily)" (1 trials), "K-877 IR 0.2 mg/day (twice daily)" (1 trials), "Lebrikizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fukuwa Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fukuwa Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fukuwa Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fukuwa Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".